Join Now

Category Archives: BioUtah News

Pfizer to Acquire Arena Pharmaceuticals

By Natalie Themm | Published December 14, 2021

Arena Pharmaceuticals, Inc. and Pfizer Inc. have entered into a definitive agreement under which Pfizer will acquire Arena.

| Tagged | Leave a comment

IONIQ’s breast cancer feasibility results published by IEEE

By admin | Published December 10, 2021

Salt Lake City, November 30, 2021 – In collaboration with two of our Scientific Advisors, IONIQ Sciences, Inc. (“IONIQ” or the “Company”), is proud to announce the prestigious IEEE Access peer-reviewed journal has published a scientific manuscript on the life-saving potential of our ‘breakthrough’ bioimpedance technology in breast cancer. “Skin Electrical Resistance as a Diagnostic […]

| Leave a comment

Recursion loops in Roche, Genentech for multibillion-dollar AI drug discovery deal

By Natalie Themm | Published December 8, 2021

The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.

| Tagged | Leave a comment

ARUP Laboratories Earns Fourth Consecutive Utah Business Best Companies To Work For Award

By Natalie Themm | Published December 8, 2021

For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.

| Tagged | Leave a comment

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022

By Natalie Themm | Published December 7, 2021

Renalytix reported financial results for the quarter ended September 30, 2021.

| Tagged | Leave a comment

Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology

By Natalie Themm | Published December 7, 2021

The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery

| Tagged | Leave a comment

Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities

By Natalie Themm | Published December 7, 2021

Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.

| Tagged | Leave a comment

Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex Test

By Natalie Themm | Published December 7, 2021

Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).

| Tagged , | Leave a comment

Foldax Receives Approval for Clinical Trial of TRIA Biopolymer Surgical Aortic Heart Valve in India

By Natalie Themm | Published December 7, 2021

Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.

| Tagged | Leave a comment

HSS and Rothman Institute/Jefferson University Hospital to Participate in Clinical Trial for Elute’s Antibiotic Loaded Bone Void Filler

By Natalie Themm | Published December 6, 2021

Collaboration Expands Clinical Sites for Trial

| Tagged | Leave a comment

NIH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS

By Natalie Themm | Published December 2, 2021

NATIONAL INSTITUTE OF HEALTH AWARDS SINTX TECHNOLOGIES PHASE 1 GRANT FOR SN-PEEK 3D PRINTED SPINAL IMPLANTS

| Tagged | Leave a comment

Fluidx Medical Technology Announces Series A Led by Multinational Strategic Investor

By Natalie Themm | Published December 1, 2021

Novel Oncology Embolic Device financing supports prospective, clinical trials and market entry

| Tagged , | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members